In a diabetic patient on insulin glargine (Lantus) 18 U daily and insulin aspart (Novolog) 5 U with a medium correction factor who received bilateral knee intra‑articular corticosteroid injections 24 hours ago and now has blood glucose ~300 mg/dL, should I add a carbohydrate snack, temporarily increase the glargine dose, and use a more aggressive correction scale?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Insulin Dose Adjustment for Corticosteroid‑Induced Hyperglycemia

Increase your Lantus dose by 20–30% immediately (from 18 U to approximately 22–24 U once daily) and add 6–8 U of Novolog before lunch and dinner to counteract the afternoon/evening glucose peak caused by morning corticosteroid dosing. 1


Understanding Corticosteroid‑Induced Hyperglycemia

  • Bilateral knee corticosteroid injections cause systemic absorption that peaks 4–12 hours post‑injection and produces disproportionate hyperglycemia during the afternoon and evening, with glucose often normalizing overnight regardless of treatment. 1
  • Glucocorticoids induce insulin resistance in the liver, adipocytes, and skeletal muscle, while simultaneously impairing pancreatic β‑cell insulin secretion—requiring 40–60% increases in prandial and correction insulin beyond baseline needs. 1, 2, 3
  • The hyperglycemic effect typically persists for 24–72 hours after a single intra‑articular injection, then gradually resolves as the steroid is metabolized. 4

Immediate Basal Insulin Adjustment

  • Increase Lantus from 18 U to 22–24 U once daily (a 20–30% increase) to address the systemic insulin resistance induced by corticosteroid absorption. 1, 2
  • Titrate basal insulin by 4 U every 3 days if fasting glucose remains ≥180 mg/dL after the initial increase, targeting a fasting range of 80–130 mg/dL. 1
  • Do not exceed 0.5 U/kg/day of basal insulin (approximately 40–50 U for most adults) without adding prandial coverage, to avoid "over‑basalization" and increased hypoglycemia risk. 1

Adding Prandial Insulin for Afternoon/Evening Hyperglycemia

  • Start Novolog 6–8 U before lunch and 6–8 U before dinner to counteract the afternoon/evening glucose peak caused by morning corticosteroid dosing. 1, 2
  • Administer Novolog 0–15 minutes before meals (ideally immediately before eating) for optimal post‑prandial control. 1
  • Increase each meal dose by 2 U every 3 days based on 2‑hour post‑prandial glucose readings, targeting post‑prandial glucose <180 mg/dL. 1

Correction Scale Adjustment

  • Use a more aggressive correction scale during the steroid effect period:
    • Pre‑meal glucose 201–250 mg/dL → add 4 U Novolog (instead of the usual 2 U). 1
    • Pre‑meal glucose 251–350 mg/dL → add 6 U Novolog (instead of the usual 4 U). 1
    • Pre‑meal glucose >350 mg/dL → add 8 U Novolog and evaluate for ketones. 1
  • These correction units are in addition to the scheduled prandial dose, not a replacement. 1

Monitoring Protocol During Steroid Effect

  • Check fasting glucose daily to guide basal insulin adjustments. 1
  • Measure pre‑meal glucose before lunch and dinner to calculate correction doses. 1
  • Obtain 2‑hour post‑prandial glucose after lunch and dinner to assess prandial adequacy and guide further titration. 1
  • Monitor for hypoglycemia 48–72 hours after the corticosteroid injection, as the steroid effect wanes and insulin requirements drop sharply. 4

Tapering Insulin as Steroid Effect Resolves

  • Reduce Lantus back to 18 U (or lower) once fasting glucose consistently falls below 100 mg/dL for 2–3 consecutive days, typically 48–72 hours post‑injection. 1, 4
  • Discontinue prandial Novolog when pre‑meal glucose consistently remains <140 mg/dL without correction doses. 1
  • Reduce insulin doses by 10–20% immediately if any glucose reading falls <70 mg/dL during the taper. 1

Carbohydrate Coverage Considerations

  • Do not add carbohydrate coverage (i.e., insulin‑to‑carbohydrate ratio dosing) during the acute steroid effect, as the primary issue is insulin resistance, not carbohydrate intake. 1, 2
  • Scheduled prandial insulin doses (6–8 U before lunch and dinner) provide adequate coverage for typical meals during the steroid effect period. 1
  • Carbohydrate counting can be reintroduced once the steroid effect resolves and insulin requirements stabilize. 1

Expected Clinical Outcomes

  • With appropriate basal and prandial insulin adjustments, glucose should fall to 140–180 mg/dL within 24–48 hours of initiating the intensified regimen. 1
  • Total daily insulin requirements may increase by 40–60% during the peak steroid effect (e.g., from 23 U/day baseline to 35–40 U/day). 1, 2
  • Glucose typically normalizes within 48–72 hours after a single intra‑articular corticosteroid injection, allowing insulin doses to be tapered back to baseline. 4

Critical Pitfalls to Avoid

  • Do not rely solely on correction insulin without increasing scheduled basal and prandial doses; this reactive approach is ineffective and condemned by major diabetes guidelines. 1
  • Do not delay adding prandial insulin when pre‑meal glucose repeatedly exceeds 180 mg/dL on high‑dose steroids; scheduled prandial coverage is required. 1
  • Never use rapid‑acting insulin at bedtime as a sole correction dose, as this markedly raises nocturnal hypoglycemia risk. 1
  • Do not continue the intensified insulin regimen beyond 72 hours without reassessing glucose patterns, as the steroid effect resolves and hypoglycemia risk increases. 1, 4

Alternative Approach: NPH Insulin for Steroid Coverage

  • If Lantus alone proves insufficient, consider adding 10–15 U NPH insulin at 8 AM (in addition to Lantus) to provide daytime basal coverage that aligns with the steroid's peak effect. 1
  • NPH given in the morning specifically targets afternoon/evening hyperglycemia caused by morning corticosteroid dosing. 1
  • This approach may be preferable if the patient has difficulty with multiple daily prandial injections. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Management of diabetes during corticosteroid therapy].

Presse medicale (Paris, France : 1983), 2000

Research

Drug selection and the management of corticosteroid-related diabetes mellitus.

Rheumatic diseases clinics of North America, 1999

Related Questions

Which nebulized corticosteroid is safest for a diabetic patient with hyperglycemia?
What is the treatment for poststeroid (corticosteroid) induced diabetes?
Can hydrocortisone (HC) be given in diabetes mellitus (DM)?
What adjustments should be made to the Lantus (insulin glargine) dose, carb ratio, and correction scale for a 25-year-old male with type 1 diabetes, body mass index (BMI) 21, and elevated fasting blood glucose level of hyperglycemia, currently on 36 units of Lantus daily?
What adjustments should be made to the treatment plan for a 45-year-old male with type 1 diabetes, who has a body mass index (BMI) of 19, is underweight, and is currently taking Lantus (insulin glargine) 20 units with a carbohydrate ratio of 1 unit per 10 grams, and has an overnight blood glucose level of 76 mg/dL?
What is the recommended operative repair technique for a patient with a prior quadriceps tendon repair using bone tunnels who now has a patellar fracture and re‑rupture of the quadriceps tendon?
How should influenza A be treated, including antiviral options, dosing, timing, and recommendations for high‑risk patients?
What are the causes of localized C7 vertebral tenderness and how should it be evaluated and managed?
Can the MRI findings cause erectile dysfunction in males?
What are the immediate assessment and management steps for a patient with suspected kidney failure?
In a male patient with known coronary artery disease who presents with sudden severe left‑leg pain, pallor, coldness, prior claudication, weak foot and diminished sensation, what is the initial diagnostic test?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.